A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax.
PloS one(2022)
摘要
Our research has found new significant AEs signals of VEN, which improved its safety information in real-world after marketing approval, and contributed to its risk control of use in clinic.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要